Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea C Lo

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Haematologica|October 9, 2025
Long-term cardiac morbidity in adolescent and young adult survivors of classical Hodgkin lymphoma: the British Columbia experienceKristin C Marr, Terry Tang, Jonathan Simkin, et al.
Pediatric Blood & Cancer|April 19, 2023
Focal versus craniospinal radiation for disseminated atypical teratoid/rhabdoid tumor following favorable response to systemic therapyPaul D Aridgides, Anita Mahajan, Bree Eaton, et al.
International Journal of Radiation Oncology, Biology, Physics|January 12, 2024
Combinatorial Approaches for Chemotherapies and Targeted Therapies With Radiation: United Efforts to Innovate in Patient CareSalma K Jabbour, Ritesh Kumar, Bethany Anderson, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2025
Multimodality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin LymphomaXin Tie, Sarah A Milgrom, Andrea C Lo, et al.
Haematologica|March 5, 2026
Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVDJiayu Yang, Diego Villa, Alina S Gerrie, et al.
Pediatric Blood & Cancer|May 27, 2023
Prognostic value of chest x-ray- and CT-defined large mediastinal adenopathy in high-risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831Andrea C Lo, Inki Lee, Qinglin Pei, et al.
British Journal of Haematology|March 15, 2023
Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group studySarah A Milgrom, Jihyun Kim, Qinglin Pei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2021
PET-Based Staging Is Cost-Effective in Early-Stage Follicular LymphomaAndrea C Lo, Lyndon P James, Anca Prica, et al.
The Lancet. Haematology|October 3, 2024
Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groupsOmran Saifi, Chelsea C Pinnix, Leslie K Ballas, et al.
Journal of the National Cancer Institute|April 11, 2026
Consensus radiation therapy organ at risk constraints for NCTN trials in hematologic malignanciesAustin J Sim, Bradford S Hoppe, Leslie K Ballas, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Haematologica|October 9, 2025
Long-term cardiac morbidity in adolescent and young adult survivors of classical Hodgkin lymphoma: the British Columbia experienceKristin C Marr, Terry Tang, Jonathan Simkin, et al.
Pediatric Blood & Cancer|April 19, 2023
Focal versus craniospinal radiation for disseminated atypical teratoid/rhabdoid tumor following favorable response to systemic therapyPaul D Aridgides, Anita Mahajan, Bree Eaton, et al.
International Journal of Radiation Oncology, Biology, Physics|January 12, 2024
Combinatorial Approaches for Chemotherapies and Targeted Therapies With Radiation: United Efforts to Innovate in Patient CareSalma K Jabbour, Ritesh Kumar, Bethany Anderson, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2025
Multimodality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin LymphomaXin Tie, Sarah A Milgrom, Andrea C Lo, et al.
Haematologica|March 5, 2026
Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVDJiayu Yang, Diego Villa, Alina S Gerrie, et al.
Pediatric Blood & Cancer|May 27, 2023
Prognostic value of chest x-ray- and CT-defined large mediastinal adenopathy in high-risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831Andrea C Lo, Inki Lee, Qinglin Pei, et al.
British Journal of Haematology|March 15, 2023
Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group studySarah A Milgrom, Jihyun Kim, Qinglin Pei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2021
PET-Based Staging Is Cost-Effective in Early-Stage Follicular LymphomaAndrea C Lo, Lyndon P James, Anca Prica, et al.
The Lancet. Haematology|October 3, 2024
Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groupsOmran Saifi, Chelsea C Pinnix, Leslie K Ballas, et al.
Journal of the National Cancer Institute|April 11, 2026
Consensus radiation therapy organ at risk constraints for NCTN trials in hematologic malignanciesAustin J Sim, Bradford S Hoppe, Leslie K Ballas, et al.
Pageof 4